XML 45 R32.htm IDEA: XBRL DOCUMENT v3.19.1
Share-based compensation (Tables)
12 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share Options Activity
For the years ended December 31, 2018 and 2017, the activity related to stock options consisted of the following: 
 
Number of
options
 
Weighted average exercise price per share
 
Weighted average
remaining
contractual term
 
Aggregate
intrinsic
value
Outstanding as of December 31, 2016
352,000

 
$
10.25

 
4.4 years
 
 
Expired
(130,000
)
 
6.25

 
 
 
 
Outstanding as of December 31, 2017
222,000

 
12.59

 
5.4 years
 

Expired
(110,000
)
 
11.17

 
 
 
 
Outstanding as of December 31, 2018
112,000

 
13.98

 
2.8 years
 

Options vested and expected to vest as of December 31, 2018
112,000

 
13.98

 
2.8 years
 

Options exercisable as of December 31, 2018
112,000

 
$
13.98

 
2.8 years
 

Unvested Balance of Options
For the years ended December 31, 2018 and 2017, the activity related to the unvested balance of options consisted of the following:
 
Number of
options
 
Weighted average exercise price per share
 
Weighted average
remaining
contractual term
Unvested as of December 31, 2016
68,750

 
$
8.91

 
8.9 years
Vested
(21,250
)
 
8.80

 
 
Unvested as of December 31, 2017
47,500

 
8.96

 
7.9 years
Vested (1)
(47,500
)
 
8.96

 
 
Unvested as of December 31, 2018

 
$

 
0.0 years

(1)47,500 shares of stock options were accelerated as a result of the Spin-off of Red Violet.
Schedule of Restricted Share Units and Restricted Stock Activity
For the years ended December 31, 2018 and 2017, activity related to unvested RSUs, common stock grants and restricted stock activity consisted of the following: 
 
Number of units
 
Weighted average
grant date fair value
Unvested as of December 31, 2016
12,407,029

 
$
8.40

Granted
2,732,000

 
5.61

Vested and delivered (1)
(3,659,520
)
 
8.29

Withheld as treasury stock (2)
(192,288
)
 
8.48

Vested not delivered (3)
(2,568,318
)
 
3.43

Forfeited
(567,998
)
 
5.65

Unvested as of December 31, 2017 (4)
8,150,905

 
9.27

Granted (5)
4,598,125

 
2.63
Vested and delivered (1)
(11,468,333
)
 
7.63
Withheld as treasury stock (2)
(875,675
)
 
6.05
Vested not delivered (3)
3,766,068

 
9.85
Forfeited
(339,125
)
 
4.68
Unvested as of December 31, 2018
3,831,965

 
$
7.95

 
(1)
Among the shares vested and delivered during the years ended December 31, 2018 and 2017, there were 6,278,318 and 34,584 shares that were vested but deferred from prior periods, respectively. See (3) below.
(2)
As discussed in Note 11, Common Shares and Preferred Shares, the increase in treasury stock was primarily attributable to shares withheld to cover statutory withholding taxes upon the vesting of RSUs. As of December 31, 2018 and 2017, there were 1,233,198 and 352,523 outstanding shares of treasury stock, respectively.
(3)
Vested not delivered represent vested RSUs or common stock grants with delivery deferred to a future time. During the year ended December 31, 2018, there was a net decrease of 3,766,068 shares included in vested not delivered, as a result of the delivery of common stock of underlying RSUs included in "vested not delivered" in prior periods. During the year ended December 31, 2017, there was a net increase of 2,568,318 shares within the same balance due to the addition of vestings subject to deferred delivery terms. As of December 31, 2018 and 2017, there were 2,909,917 and 6,675,985 outstanding RSUs or shares of common stock grants included in vested not delivered, respectively.
(4)
As of December 31, 2017, included in the unvested shares were 150,000 shares of unvested restricted stock, which were, as of December 31, 2017, included in the issued and outstanding shares of the Company’s common stock.
(5)
As discussed in "Spin-off of Red Violet" above, included in the RSUs granted during the year ended December 31, 2018, were an aggregate of 304,000 shares of Spin-off Grants that vested and were delivered in the first quarter of 2018, and an aggregate of 2,041,000 shares of Transaction Grants that vested but were subject to deferred delivery over a three-year period.
Schedule of Share-based Compensation
For the years ended December 31, 2018 and 2017, share-based compensation for the Company’s stock options, RSUs, common stock grants and restricted stock was allocated to the following accounts in the consolidated financial statements: 
 
Year Ended December 31,
(In thousands)
2018
 
2017
Sales and marketing expenses
$
2,856

 
$
2,254

Product development
676

 
423

General and administrative expenses
5,739

 
28,448

Spin-off transaction costs
5,410

 

Discontinued operations
15,712

 
2,871

 
30,393

 
33,996

Capitalized in intangible assets of continuing operations
423

 
512

Capitalized in intangible assets of discontinued operations
181

 
784

Total
$
30,997

 
$
35,292